Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia
Thomas O’Bryan(Henry M. Jackson Foundation), Brian K. Agan(Henry M. Jackson Foundation), William P. Bradley(Henry M. Jackson Foundation), Jason F. Okulicz(Gilead Sciences (United States)), Xun Wang(Henry M. Jackson Foundation), Anuradha Ganesan(Walter Reed National Military Medical Center)
Cited by 25
Related Papers
Trimethoprim-Sulfamethoxazole Revisited
|Archives of Internal Medicine|2003|401
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
|New England Journal of Medicine|2013|358
Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History Study
|The Journal of Infectious Diseases|2009|305
Invasive Mold Infections Following Combat-related Injuries
|Clinical Infectious Diseases|2012|191
Epidemiology and clinical characteristics of elite controllers
|Current Opinion in HIV and AIDS|2011|176